Dataset Open Access

The process of HDAC11 Assay Development: linearity and Km calculation

Abbey, Megha; Vedadi, Masoud

With previously optimized conditions, the linearity range for HDAC11 was obtained and the Km for the substrate was calculated.

 

Note: 1. In the assay buffer, BSA conc. is 0.5 mg/ml (instead of 0.5%).

          2. In the 7.5 ul developer solution, 40 uM of TSA (Trichostatin A) is also included.

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (237.6 kB)
Name Size
4june2018-HDAC11 assay deve process-linearity-Km.pdf
md5:ab7cfc34561393a3eb8d48991a0388ca
237.6 kB Download
105
43
views
downloads
All versions This version
Views 105105
Downloads 4343
Data volume 10.2 MB10.2 MB
Unique views 8888
Unique downloads 4040

Share

Cite as